Nebivolol, an FDA-Approved Drug, Has General Antibacterial and Antibiofilm Effects and Increases Pseudomonas aeruginosa Tolerance to Ciprofloxacin

奈必洛尔是一种经FDA批准的药物，具有广谱抗菌和抗生物膜作用，并能增强铜绿假单胞菌对环丙沙星的耐受性。